William J. Newell
2019
In 2019, William J. Newell earned a total compensation of $3.8M as Chief Executive Officer at SUTRO BIOPHARMA, a 56% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $223,425 |
|---|---|
| Option Awards | $3,097,200 |
| Salary | $496,500 |
| Total | $3,817,125 |
Newell received $3.1M in option awards, accounting for 81% of the total pay in 2019.
Newell also received $223.4K in non-equity incentive plan and $496.5K in salary.
Rankings
In 2019, William J. Newell's compensation ranked 3,143rd out of 13,971 executives tracked by ExecPay. In other words, Newell earned more than 77.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,143 out of 13,971 | 78th |
Division Manufacturing | 1,136 out of 5,698 | 80th |
Major group Chemicals And Allied Products | 386 out of 2,197 | 82nd |
Industry group Drugs | 317 out of 1,883 | 83rd |
Industry Biological Products, Except Diagnostic Substances | 74 out of 389 | 81st |
Source: SEC filing on April 24, 2020.
Newell's colleagues
We found four more compensation records of executives who worked with William J. Newell at SUTRO BIOPHARMA in 2019.
News
SUTRO BIOPHARMA CEO William Newell's 2021 pay jumps 161% to $5.6M
April 22, 2022
SUTRO BIOPHARMA CEO William Newell's 2020 pay falls 44% to $2.2M
April 29, 2021
SUTRO BIOPHARMA CEO William Newell's 2019 pay falls 56% to $3.8M
April 24, 2020
SUTRO BIOPHARMA CEO William Newell's 2018 pay jumps 1,136% to $8.7M
April 25, 2019